Revisiting Anti-TNFs: Role, Risks, and Real-World Considerations
Michael Dolinger, MD, MBA
David T. Rubin, MD
The Future of Biologic Treatment in IBD: What’s on the Horizon
Small Molecules in IBD: JAK Inhibitors and S1P Modulators
Florence Odufalu, MD
Beyond One-Size-Fits-All: Individualizing First-Line IBD Treatment
Gut-Selective Therapy: Understanding Anti-Integrins in IBD
IBD Care Reimagined: Personalized, Proactive, and Target-Driven Management
Ugo Iroku, MD, MHS
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
Defining Success in IBD: Treat-to-Target
Putting It All Together: A Practical IBD Treatment Selection Primer
Setting the Stage: Why Rethinking IBD Care Matters Now
Beyond Biology: Environmental and Lifestyle Influences in IBD
Putting It All Together: Challenges Addressed
Targeting Inflammation in IBD: Localized vs Systemic Strategies
Severity Assessment: Can You Pin the Stage on the Patient?
Jennifer Geremia, PA-C
Brooke Hodnick, PA-C, MPAS
Case Review: Targets Are Met—Can You Stick the Landing?
David Rubin, MD
Remission: Can You Prove It?
Kimberly D. Orleck, PA-C
IBD Immunopathogenesis: Do You Know What You're Blocking?
Loading...
We're glad to see you're enjoying Crohn's Colitis Professional… but how about a more personalized experience?
Press cancel to remain on Crohn's Colitis Professional. Press the link below or the continue button to keep going.